MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    The course of Parkinson’s disease in patients with impaired carbohydrate metabolism

    F. Akhmedova, B. Shagazatova, D. Artikova, F. Mirxaydarova (Tashkent, Uzbekistan)

    Objective: To study the state of lipid metabolism in PD patients with concomitant type 2diabetes (with different glucose tolerance and the effect of DA agonist…
  • 2018 International Congress

    A single center retrospective analysis of Opicapone treatment in 90 Parkinson patients

    M. Winterholler, H. Erxleben (Schwarzenbruck, Germany)

    Objective: To evaluate retrospectively the treatment with the novel COMT-inhibitor opicapone (OPC) in a tertiary Parkinson Center the first year after its approval in Germany…
  • 2018 International Congress

    Long Term Outcome of the Subthalamic Nucleus DBS for Advanced Parkinson’s Disease: An Eight Years Follow-Up Study in China

    Q. Guo, J. Liu, C. Yang, W. Xian, L. Jiang, S. Xu, W. Chen, Y. Hu, L. Chen (Guangzhou, China)

    Objective: To investigate the long term efficacy and its safety of STN DBS for PD in China with an eight years follow up of ten…
  • 2018 International Congress

    Impact of Disease Duration and Anatomical Target on Health Related QoL in Patients Receiving DBS: Results from the Product Surveillance Registry

    M. Schiess, S. Falowski, S. Palfi, J. Azulay, A. Lopez-Rios, L. Defebvre, J. Espinoza, K. Sandberg, B. Van Dorn, T. Weaver, P. Konrad, J. Krauss (Houston, TX, USA)

    Objective: Summarize change in quality of life (QoL) by comparing scores from the EuroQuol-five domain questionnaire, five level response version (EQ-5D-5L) summary index obtained at…
  • 2018 International Congress

    Inpatient care for Parkinson’s disease in Germany: Analysis of more than one million cases from the years 2010 to 2015

    L. Tönges, D. Bartig, S. Muhlack, W. Jost, R. Gold, C. Krogias (Bochum, Germany)

    Objective: Analyze the characteristics and dynamics of inpatient care for Parkinson's disease in Germany. Background: Parkinson's disease is the most common neurodegenerative movement disorder with…
  • 2018 International Congress

    Auto-antibodies and clinical-imaging associations in patients with Movements Disorders from a Neurological Institute in Mexico

    H. Martinez-Hernandez, N. Gandarilla-Martinez, J. Flores-Rivera, O. Cardenas-Saenz, R. Garcia-Santos, V. Rivas, N. Kerik-Rotenberg, S. Vargas-Cañas, M. Espinola-Nadurille (Mexico City, Mexico)

    Objective: Determine the prevalence of systemic and anti-neuronal antibodies in Movement Disorders patients from a third-level neurological hospital. Background: Autoimmunity is a common cause of…
  • 2018 International Congress

    Is there a role for miRNA in the diagnosis of PD?

    A. Garvey, N. Cutfield, J. Williams (Dunedin, New Zealand)

    Objective: Several studies have examined mirco RNA (miRNA) in Parkinson's disease with the aim of finding a diagnostic test; so what utility have miRNA in…
  • 2018 International Congress

    Atypical Dopamine Responsive Parkinsonism in HIV Seroconversion

    N. Siddi Ganie, I. Siddi Ganie, N. Soni (Durban, South Africa)

    Objective: To add to the current body of knowledge of the association of HIV infection and dopamine responsive parkinsonism. Background: South Africa has one of…
  • 2018 International Congress

    The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy

    P. Huang, H.Y. Zhou, Y.Y. Tan, S.D. Chen (Shanghai, China)

    Objective: To evaluate the differential diagnosis value of transcranial sonography (TCS) between Parkinson’s disease (PD) and multiple system atrophy (MSA) Background: The differential diagnosis of…
  • 2018 International Congress

    Clinical indicators of advanced Parkinson’s disease: Evaluating diagnostic properties from retrospective analysis of multi-country, cross-sectional observational study

    P. Odin, Z. Pirtosek, R. Rodriguez, P. Martinez-Martin, D. Shah, P. Kandukuri, O. Koray, J. Zamudio, Y. Bao, Y. Jalundhwala, A. Antonini (Lund, Sweden)

    Objective: To measure the diagnostic properties of clinical indicators of advanced Parkinson Disease (APD). Background: Lack of consensus to define APD may lead to delay…
  • « Previous Page
  • 1
  • …
  • 267
  • 268
  • 269
  • 270
  • 271
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley